Dr. Gadiparthi is on Doximity
As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office254 Easton Ave
New Brunswick, NJ 08901
- Is this information wrong?
- Dr. Chiranjeevi Gadiparthi is a Gastroenterologist in New Brunswick, NJ and is affiliated with Saint Peter’s University Hospital/Rutgers RWJ Medical School. He received his medical degree from Kurnool Medical College, Internal Medicine Residency at Texas Tech University HSC and Transplant Hepatology at University Tennessee HSC, Memphis TN. He specializes in Gastroenterology, Endoscopy, Hepatology, liver transplantation and Hepatobiliary Diseases.
Education & Training
- University of Tennessee Health Science CenterFellowship, Transplant Hepatology , 2016 - 2017
- Texas Tech University Health Sciences CenterResidency, Internal Medicine, 2009 - 2012
- Kurnool Medical CollegeClass of 2004
- University of Tennessee Health Science CenterFellowship, Transplant Hepatology
Certifications & Licensure
- PA State Medical License 2021 - 2022
- NJ State Medical License 2018 - 2021
- TX State Medical License 2016 - 2022
- TN State Medical License 2012 - 2018
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
- 17 citationsSARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19.Aristides M. Tsatsakis, Daniela Calina, Luca Falzone, Dimitrios Petrakis, Radu Mitrut, Vasileios Siokas, Manuela Pennisi, Giuseppe Lanza, Massimo Libra, Sotirios G Dou...> ;Food and Chemical Toxicology. 2020 Sep 30
- 5 citationsHyperglycemia, Hypertriglyceridemia, and Acute Pancreatitis in COVID-19 Infection: Clinical Implications.Chiranjeevi Gadiparthi, Mehak Bassi, Balaji Yegneswaran, Sammy Ho, Capecomorin S. Pitchumoni> ;Pancreas. 2020 Aug 1
- 2 citationsOpioid Use Disorder Increases 30-Day Readmission Risk in Inflammatory Bowel Disease Hospitalizations: a Nationwide Matched Analysis.Paris Charilaou, Sonmoon Mohapatra, Tejas V. Joshi, Kalpit Devani, Chiranjeevi Gadiparthi, Capecomorin S. Pitchumoni, Debra Goldstein> ;Journal of Crohn's and Colitis. 2020 Jun 19
- Join now to see all
- Changing Trends in Etiology‐ and Ethnicity‐Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United StatesZobair M Younossi, Donghee Kim, Chiranjeevi Gadiparthi, Brandon J Perumpail, Hepatology
- Saint Peter's University HospitalNew Brunswick, New Jersey
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: